Drawing for TAIHO ONCOLOGY

USPTO serial 79153864

TAIHO ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 4762507Status 404
Filing date
Status date
Registration date
Jun 30, 2015
Examiner
KENEALY, NATALIE LANGFORD
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TAIHO ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-cancer pharmaceutical preparations and substances; anti-ulcerogenic pharmaceutical preparations and substances; pharmaceutical preparations and substances for the treatment of immunological diseases; pharmaceutical preparations and substances for the treatment of urinary diseases; therapeutic preparations and substances for pain; antiemetic preparations and substances; diagnostic preparations for medical use and diagnostic substances in the nature of reagents for medical use; drugs for genetic testing; pharmaceutical preparations for the prevention and treatment of cancerSECTION 71 - CANCELLED—
044Medical diagnostic services of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing information relating to the treatment or prevention of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical consultation services relating to the treatment and diagnosis of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; Medical services in the nature of medical analysis services and genetic testing for the diagnosis and prognosis of the expected progression of cancer, tumor, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to efficacy, side effects, interactions of pharmaceuticals and medication; medical services; providing medical information; physical examination; dentistry; preparation and dispensing of medicationsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 31, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 4, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 4, 2022INPCINVALIDATION PROCESSED—
Sep 14, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 14, 2022C71TCANCELLED SECTION 71—
Nov 17, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 23, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 23, 2015FIMPFINAL DISPOSITION PROCESSED—
Sep 30, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 30, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 14, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2015GPNXNOTIFICATION PROCESSED BY IB—
Mar 25, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 25, 2015NPUBNOTICE OF PUBLICATION—
Mar 10, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 2, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 10, 2015ALIEASSIGNED TO LIE—
Feb 3, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 28, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 13, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 13, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 11, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 10, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 3, 2014DOCKASSIGNED TO EXAMINER—
Nov 3, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance